ANAVEX (AVXL) is running PD trials

[John_morris71]

Currently enrolling for Phase 2 in Spain. Results should be out by end of year or early next year. Let us hope for the best. They are using precision medicine to focus on Sigma 1 receptor, and the MOA is different than what conventionally BP has followed. Go to the IHUB board - AVXL for more details.

[park_bear]

This treatment is for Parkinson's disease dementia.

[John_morris71 in reply to park_bear]

You are right. But read more about sigma 1 receptor and its benefits to the CNS - Central Nervous System. They also have trials for AD going on in Australia. May be a game changer. Good to wait and watch.

[John_morris71 in reply to park_bear]

pdlink.org/phase-2-trial-te...

"Trial participants will be randomly assigned to receive orally 10 or 20 mg of Anavex 2-73 or a placebo for 14 weeks.

Researchers will evaluate the impact of the treatment on cognition, as determined by the cognitive drug research computerized assessment system, as well as on patients’ motor function and sleep quality. "

Let us hope the new approach works.

[Ummehala82]

Hopeful and grateful